CH614436A5 - - Google Patents
Info
- Publication number
- CH614436A5 CH614436A5 CH1160676A CH1160676A CH614436A5 CH 614436 A5 CH614436 A5 CH 614436A5 CH 1160676 A CH1160676 A CH 1160676A CH 1160676 A CH1160676 A CH 1160676A CH 614436 A5 CH614436 A5 CH 614436A5
- Authority
- CH
- Switzerland
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
- C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
- C07D265/30—1,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR7529819A FR2325379A1 (fr) | 1975-09-29 | 1975-09-29 | Nouveaux derives de 2-(2-hydroxyethyl)tetrahydro-1,4 oxazines substituees et leur application comme medicaments antispasmodique |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CH614436A5 true CH614436A5 (xx) | 1979-11-30 |
Family
ID=9160603
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CH1160676A CH614436A5 (xx) | 1975-09-29 | 1976-09-13 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US4062956A (xx) |
| JP (1) | JPS5262284A (xx) |
| AU (1) | AU498800B2 (xx) |
| BE (1) | BE845629A (xx) |
| CA (1) | CA1070689A (xx) |
| CH (1) | CH614436A5 (xx) |
| DE (1) | DE2642930A1 (xx) |
| ES (1) | ES451918A1 (xx) |
| FR (1) | FR2325379A1 (xx) |
| GB (1) | GB1535830A (xx) |
| NL (1) | NL7610742A (xx) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2651732C (en) | 2006-05-18 | 2014-10-14 | Mannkind Corporation | Intracellular kinase inhibitors |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH471146A (de) * | 1966-03-16 | 1969-04-15 | Geigy Ag J R | Verfahren zur Herstellung von neuen Morpholinderivaten |
-
1975
- 1975-09-29 FR FR7529819A patent/FR2325379A1/fr active Granted
-
1976
- 1976-08-27 BE BE170172A patent/BE845629A/xx unknown
- 1976-09-13 CH CH1160676A patent/CH614436A5/xx not_active IP Right Cessation
- 1976-09-16 US US05/724,068 patent/US4062956A/en not_active Expired - Lifetime
- 1976-09-17 AU AU17866/76A patent/AU498800B2/en not_active Expired
- 1976-09-24 CA CA261,986A patent/CA1070689A/en not_active Expired
- 1976-09-24 DE DE19762642930 patent/DE2642930A1/de not_active Withdrawn
- 1976-09-28 JP JP51116474A patent/JPS5262284A/ja active Pending
- 1976-09-28 NL NL7610742A patent/NL7610742A/xx not_active Application Discontinuation
- 1976-09-28 ES ES451918A patent/ES451918A1/es not_active Expired
- 1976-09-28 GB GB40204/76A patent/GB1535830A/en not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| NL7610742A (nl) | 1977-03-31 |
| BE845629A (fr) | 1977-02-28 |
| ES451918A1 (es) | 1977-08-16 |
| AU498800B2 (en) | 1979-03-22 |
| CA1070689A (en) | 1980-01-29 |
| AU1786676A (en) | 1978-03-23 |
| FR2325379B1 (xx) | 1979-01-12 |
| FR2325379A1 (fr) | 1977-04-22 |
| JPS5262284A (en) | 1977-05-23 |
| DE2642930A1 (de) | 1977-03-31 |
| GB1535830A (en) | 1978-12-13 |
| US4062956A (en) | 1977-12-13 |
Similar Documents
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PL | Patent ceased |